Early research (Phase 1)Ended earlyNCT02628535What this trial is testingSafety Study of MGD009 in B7-H3-expressing TumorsWho this might be right forMesotheliomaBladder CancerMelanoma+10 more MacroGenics 67
Testing effectiveness (Phase 2)Study completedNCT04693507What this trial is testingTeverelix Evaluated in Advanced Prostate CancerWho this might be right forProstatic Adenoma Antev Ltd. 50
Early research (Phase 1)Study completedNCT00703638What this trial is testingSorafenib, Pemetrexed, and Cisplatin in Treating Patients With Advanced Solid TumorsWho this might be right forBreast CancerColorectal CancerHead and Neck Cancer+5 more Masonic Cancer Center, University of Minnesota 16
Not applicableWithdrawnNCT04985357What this trial is testingDefining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to DrugsWho this might be right forStage III Breast CancerStage IV Breast CancerStage III Lung Cancer+35 more Travera Inc
Early research (Phase 1)Study completedNCT00423254What this trial is testingSafety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer.Who this might be right forOvarianMelanomaRenal+20 more Mannkind Corporation 12
Not applicableWithdrawnNCT05157724What this trial is testingObservational Study to Compare Two Prostate Laser Enucleation Techniques in Terms of Urinary IncontinenceWho this might be right forProstatic Hyperplasia, BenignProstatic Adenoma Elsan
Not applicableStudy completedNCT00428220What this trial is testingA Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.Who this might be right forMetastatic Breast CancerAdvanced Breast CancerMetastatic Castration Resistant Prostate Cancer+9 more Pfizer 223
Not applicableStudy completedNCT02585362What this trial is testingWhey Protein Supplement in Combination With Physical Exercise and Nutrition ProgramWho this might be right forLung CancerGastro-Intestinal CancerBreast Cancer+5 more Kantonsspital Winterthur KSW 52
Early research (Phase 1)Study completedNCT04430842What this trial is testingDose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072SWho this might be right forAstrocytomaBrain CancerBrain Metastases+20 more Quadriga Biosciences, Inc. 15
Not applicableStudy completedNCT01135849What this trial is testingB-Receptor Signaling in CardiomyopathyWho this might be right forCarcinomasAmyloidosisAnal Cancer+35 more Daniel Bernstein 99
Not applicableStudy completedNCT00372840What this trial is testingPrinted Education Materials in Patients Who Are Finishing Treatment for Stage I, Stage II, or Stage IIIA Breast Cancer, Colorectal Cancer, Prostate Cancer, or Chest CancerWho this might be right forBreast CancerColorectal CancerLung Cancer+4 more Fox Chase Cancer Center 340
Not applicableLooking for participantsNCT03784924What this trial is testingEDRN Prostate MRI Biomarker StudyWho this might be right forPSAProstate Cancer University of Michigan 950
Not applicableStudy completedNCT00477919What this trial is testingE-MOSAIC Electronic Tool to Monitor SymptomsWho this might be right forCancer Swiss Cancer Institute 264
Early research (Phase 1)Ended earlyNCT05047536What this trial is testingKZR-261 in Subjects With Advanced Solid MalignanciesWho this might be right forAdvanced/Metastatic Solid Tumor Kezar Life Sciences, Inc. 61
Early research (Phase 1)Study completedNCT00413322What this trial is testingStudy of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid TumorsWho this might be right forTumor Valerio Therapeutics 35
Early research (Phase 1)Active Not RecruitingNCT05215574What this trial is testingStudy of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid TumorsWho this might be right forPancreatic CancerBreast CancerGastric Cancer+13 more NGM Biopharmaceuticals, Inc 130
Testing effectiveness (Phase 2)Looking for participantsNCT05944237What this trial is testingHTL0039732 in Participants With Advanced Solid TumoursWho this might be right forNeoplasmsProstatic Neoplasms, Castration-ResistantStomach Neoplasms+11 more Cancer Research UK 150
Testing effectiveness (Phase 2)Active Not RecruitingNCT04802876What this trial is testingEfficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Expressing TumorsWho this might be right forMSI-H Colorectal CancerMelanomaAnal Carcinoma+28 more SOLTI Breast Cancer Research Group 184
Testing effectiveness (Phase 2)Study completedNCT01220817What this trial is testingSafety and Efficacy of POMx Capsules in Men With Recurrent Prostate Cancer: An 18-Month StudyWho this might be right forRecurrent Prostate Cancer POM Wonderful LLC 104
Testing effectiveness (Phase 2)WithdrawnNCT05582031What this trial is testingRegorafenib With Tislelizumab in Patients With Selected Mismatch Repair-Proficient/Microsatellite Stable CancersWho this might be right forAnal Squamous Cell CarcinomaColorectal NeoplasmsSoft Tissue Sarcoma+5 more Translational Research in Oncology